3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow Valvular Heart Disease: new trials by email Literature Review of Valvular Heart Disease trials Research Report on Valvular Heart Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial Rivaroxaban, Warfarin - Valvular Heart Disease | Phase 2 | Completed | Hospital do Coracao | 1005 | 2015-08-01 | 2022-04-12 |
| The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass ERAS group, Conventional control group - Valvular Heart Disease | Phase 2 | Completed | Xiangya Hospital of Central South University | 226 | 2015-07-01 | 2017-06-01 |
| Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent Custodiol HTK, Cold Blood Cardioplegia - Coronary Artery Disease, Myocardial Ischemia | Phase 2 | Completed | Marc Sakwa, MD | 110 | 2012-08-01 | 2019-08-06 |
Heart Valve Diseases (3) · Coronary Artery Disease (1) · Coronary Disease (1) · Heart Diseases (1) · Myocardial Ischemia (1)
Cardiovascular Diseases (3) · Heart Diseases (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Vascular Diseases (1)
Bretschneider cardioplegic solution (1) · Dexamethasone (1) · Methylprednisolone Hemisuccinate (1) · Morphine (1) · Rivaroxaban (1) · Scopolamine (1) · Warfarin (1)
Hospital do Coracao (1) · Marc Sakwa, MD (1) · Xiangya Hospital of Central South University (1)
Brazil (1) · China (1) · United States (1)
Marc Sakwa, M.D. (1) · Otavio Berwanger, MD, PhD (1) · Ricardo Pavanello, MD, PhD (1)
PMID 14667752, PMID 22797672, PMID 25791027, PMID 29514224, PMID 33045224, PMID 33196155